While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

This Collection supports and amplifies research related to SDG 9 - Industry, Innovation & Infrastructure. Generative modeling for chemistry discovery is an emerging field at the intersection of ...

Artificial intelligence is no longer confined to data crunching and automation; it's making profound inroads into the creative industries. Generative models like generative adversarial networks (GANs) ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I will identify and discuss an important AI ...

Researchers have found that training successive generations of generative artificial intelligence models on synthetic data gives rise to self-consuming feedback loops. Generative artificial ...

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

Even for those who follow the AI video space, it can be hard to tell exactly which models are live and available at any given ...

Researchers have developed a systematic review that charts the evolution of artificial intelligence in generative design for steel modular structures, particularly steel box modular buildings, ...

Bio (NASDAQ:IBIO) is seeking to narrow what it views as a growing “trust gap” between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market, ...

Google has begun rolling out private access to its Veo and Imagen 3 generative AI models. Starting today, customers of the company’s Vertex AI Google Cloud package can begin using Veo to generate ...